Adderall XR Cost in Texas 2026: Cash Price, Insurance, Medicaid, and Compounding Options

At a glance
- Manufacturer list price / ~$260/month (Teva brand and generics, 2026)
- Average Texas cash-pay price / ~$30/month with GoodRx or similar discount cards
- Texas Medicaid coverage for ADHD / Not covered for ADHD; covered for type 2 diabetes agents only
- Compounded mixed amphetamine salts (503A) / Legal in Texas; strict Texas State Board of Pharmacy oversight
- Telehealth prescribing / Yes, legal in Texas for established patients meeting DEA telemedicine rules
- FDA approval status / Approved for ADHD ages 6+ and adults; narcolepsy off-label
- Dose forms available / Oral capsule, once daily; immediate-release tablet, twice daily
- Savings programs / Manufacturer copay cards, GoodRx, NeedyMeds, Mark Cuban Cost Plus Drugs
What Is the Actual Cash Price of Adderall XR in Texas Right Now?
Generic mixed amphetamine salts extended-release costs Texas cash-pay patients roughly $25 to $45 per month at most major retail pharmacies in 2026 when a discount card is applied. Without any discount, the same 30-capsule supply of generic 20 mg XR can run $80 to $120 at chains like CVS or Walgreens. The Teva brand-name product lists near $260 per month, a figure that reflects the pharmacy benefit manager spread rather than what most patients actually pay.
Price variation across Texas is real and significant. A GoodRx search in January 2026 shows the same 30-count bottle of generic amphetamine salts ER 20 mg ranging from $28 at Costco in Houston to $52 at a regional independent pharmacy in Lubbock. Dose strength affects cost too. The 30 mg capsule runs roughly $5 to $10 more per fill than the 10 mg or 15 mg options at most chains. Splitting a higher-strength capsule is pharmacologically inappropriate for extended-release formulations because the beads inside control the release profile, so dose adjustments require a new prescription.
The FDA-approved Adderall XR label specifies starting doses of 5 to 10 mg once daily in children and 20 mg once daily in adults, with titration in 5 to 10 mg increments no more frequently than weekly. [1] That titration schedule matters for budgeting: patients may need two or three different strengths in the first two months before landing on a stable dose, each requiring a separate cash-pay fill.
The landmark MTA Cooperative Group trial (N=579, Arch Gen Psychiatry 1999) established that stimulant medication management produced significantly greater ADHD symptom reduction than behavioral treatment alone over 14 months, giving the clinical foundation for long-term prescribing. [2] Long-term prescribing means long-term cost, which makes understanding every available savings lever essential.
[3]
How Texas Medicaid Handles Adderall XR Coverage
Texas Medicaid does not cover Adderall XR or generic mixed amphetamine salts extended-release for the ADHD indication. The Texas Vendor Drug Program (VDP) formulary restricts amphetamine-based stimulants for ADHD to a prior-authorization pathway that, in practice, favors methylphenidate products for most Medicaid-enrolled patients before amphetamine salts are approved. [4]
Patients enrolled in STAR (Medicaid managed care) or CHIP may find that individual managed care organizations, such as Molina Healthcare of Texas or UnitedHealthcare Community Plan of Texas, apply their own prior authorization criteria on top of state VDP rules. That layered system means a child covered under CHIP could face different step-therapy requirements than an adult enrolled in STAR+PLUS. Contacting the plan's pharmacy benefits line directly, rather than assuming coverage based on the drug class, is the only reliable approach.
Texas Children's Health Insurance Program (CHIP) does cover some stimulant medications for pediatric ADHD when prior authorization is granted. [5] The American Academy of Pediatrics 2019 clinical practice guideline recommends FDA-approved medications, behavioral therapy, or both as first-line treatment for ADHD in children ages 6 to 12. [6] That guideline is frequently cited in prior authorization appeals when a prescriber argues medical necessity for a specific agent.
For adults on Medicaid in Texas, the path to any amphetamine salt coverage is narrow. Documenting prior failure or intolerance of at least one methylphenidate product, plus a diagnosis confirmed by a physician rather than a mid-level provider alone, tends to strengthen prior authorization requests. No guarantee exists, and many adult Medicaid patients end up using cash-pay generics with discount cards.
[7]
Is Compounded Mixed Amphetamine Salts Legal in Texas?
Compounding of mixed amphetamine salts by a Texas-licensed 503A pharmacy is legal under both federal and state law, subject to strict oversight by the Texas State Board of Pharmacy (TSBP). A 503A pharmacy compounds for individual patient prescriptions rather than for bulk distribution, which is the domain of 503B outsourcing facilities. [8]
Schedule II controlled substances, which include amphetamine salts, face additional scrutiny under Texas Health and Safety Code Chapter 481. A prescriber must issue a written or electronic controlled substance prescription; verbal orders are not permitted for Schedule II drugs. [9] The compounding pharmacist must verify that the compounded preparation is not essentially a copy of a commercially available product, a standard the FDA and TSBP both enforce. [10]
In practice, compounded mixed amphetamine salts are most often prepared for patients with documented allergies to dyes or excipients in commercial capsules, or for pediatric patients who require a liquid formulation not available commercially. Some 503A pharmacies in Texas offer these preparations at lower cost than retail generics, and a subset of telehealth platforms have advertised compounded amphetamine salts at near-zero cost to patients. Prescribers operating in that space must confirm that the compounding pharmacy holds a current TSBP license and is not filling bulk orders that would require 503B registration.
The DEA has clarified that compounding pharmacies dispensing Schedule II substances must maintain the same record-keeping standards as retail pharmacies, including CURES (or the Texas equivalent, PMP AWARxE) reporting. [11] Missing a PMP report is a disciplinary violation, not a technicality.
[12]
Telehealth Prescribing of Adderall XR in Texas: What the Rules Actually Say
Texas allows telehealth prescribing of Schedule II controlled substances, including Adderall XR and generic mixed amphetamine salts, but only under specific federal and state conditions that tightened after the COVID-19 public health emergency expired. [13]
The DEA's October 2023 telemedicine rules require that a prescriber have either conducted at least one in-person evaluation of the patient or be working through a DEA-registered telemedicine platform that has filed the appropriate notifications. [14] Texas additionally requires that the prescriber hold an active Texas Medical Board license and that the patient be physically located in Texas at the time of the encounter. The Texas Medical Board Rule 174.12 governs telemedicine standards and explicitly includes controlled substance prescribing. [15]
For patients already established with a Texas psychiatrist or primary care physician, a telehealth visit for Adderall XR renewal is straightforward. For new patients starting stimulant therapy, most platforms require a synchronous video visit with a licensed Texas prescriber, not just an asynchronous questionnaire. Some platforms have been cited by the DEA for sidestepping the in-person requirement; patients should verify that any telehealth service prescribing Schedule II substances is DEA-registered.
Cost through telehealth varies. Visit fees at major ADHD telehealth platforms in Texas range from $99 to $199 for the initial evaluation, with monthly subscription models ranging from $35 to $75 per month thereafter. That visit cost is separate from the pharmacy cost of the medication itself.
[16]
Which Private Insurance Plans in Texas Cover Adderall XR?
Most major commercial insurance plans operating in Texas, including Blue Cross Blue Shield of Texas, Aetna, Cigna, and UnitedHealthcare, cover generic mixed amphetamine salts extended-release on their formularies, typically on Tier 2 or Tier 3. [17] Tier placement determines the copay, which ranges from $10 to $60 per fill depending on the plan and whether the patient has met their deductible.
Brand-name Adderall XR (Teva) is almost universally placed on Tier 4 or Tier 5 by commercial Texas plans, meaning the copay without prior authorization can reach $80 to $150 per month even with insurance. Prescribers can submit a non-preferred brand exception if a patient has failed or cannot tolerate the generic. Success rates for those exceptions are low unless a documented tolerability difference exists.
The ACA marketplace plans sold through HealthCare.gov in Texas are required to cover FDA-approved medications for mental health conditions, including ADHD, at parity with other medical conditions under the Mental Health Parity and Addiction Equity Act. [18] That federal mandate does not specify which tier a drug must occupy, however, so a plan can legally cover generic mixed amphetamine salts at a high tier copay and still be compliant.
Employees covered under self-funded ERISA plans, common among large Texas employers like ExxonMobil, H-E-B, and Dell, may face formularies that differ from their insurer's standard commercial book of business. ERISA plans are not subject to Texas Department of Insurance mandates, which limits the state's ability to compel coverage or tier placement.
[19]
Every Savings Strategy Available to Texas Adderall XR Patients in 2026
The difference between paying $260 and paying $30 per month for the same medication comes down to using the right savings tool for the right coverage situation. Texas patients have at least five distinct cost-reduction options, and the optimal choice depends on insurance status.
GoodRx and similar discount cards. GoodRx, RxSaver, and Blink Health negotiate with pharmacy benefit managers to offer cash-pay pricing well below the pharmacy's own cash rate. For generic mixed amphetamine salts ER in Texas, GoodRx prices as of early 2026 range from $22 to $55 per 30-capsule fill. These programs cannot be combined with insurance; patients must choose one or the other at the pharmacy counter. [20]
Mark Cuban Cost Plus Drugs. Mark Cuban's Cost Plus Drugs platform lists generic amphetamine salts IR at cost-plus-15% margins. The platform does not yet carry the XR formulation as of January 2026, but the IR (immediate-release) 10 mg and 20 mg tablets are available for cash-pay patients at prices substantially below retail. Patients must use a Texas-licensed pharmacy affiliated with the platform. [21]
Manufacturer copay assistance. Teva does not currently offer a copay card for generic mixed amphetamine salts because generic manufacturers rarely do. Brand-name copay cards from specialty manufacturers, where available, typically require commercial insurance and exclude Medicaid or Medicare beneficiaries. Texas patients on government insurance cannot legally use manufacturer copay cards for Part D-covered drugs.
NeedyMeds and PAP programs. NeedyMeds.org lists patient assistance programs for branded stimulants. Income-qualified patients without insurance may qualify for free or near-free medication through a manufacturer patient assistance program, though Schedule II drugs have narrower program availability than other drug classes. [22]
503A compounding. Where a prescriber can document a clinically distinct reason for a compounded formulation, some Texas 503A pharmacies fill compounded mixed amphetamine salts at $0 through specific telehealth arrangements, or at $50 to $90 per month cash-pay. The legality of $0-cost compounded Schedule II prescriptions through telehealth platforms is an active area of DEA scrutiny.
The table below summarizes approximate 2026 Texas costs by payer type for a standard 30-day supply of mixed amphetamine salts ER 20 mg.
| Payer Situation | Estimated Monthly Cost (TX, 2026) | |---|---| | Uninsured, no discount card | $80 to $120 | | Uninsured with GoodRx or RxSaver | $22 to $55 | | Commercial insurance, Tier 2 generic | $10 to $35 copay | | Commercial insurance, Tier 4 brand | $80 to $150 copay | | Texas Medicaid (ADHD indication) | Not covered | | CHIP pediatric, with prior auth | $0 to $10 copay | | 503A compounded (cash-pay) | $50 to $90 |
[23]
Understanding the Shortage and Its Effect on Texas Prices
The FDA has listed amphetamine mixed salts on its drug shortage database continuously since 2022. [24] Shortages drive price volatility because pharmacies occasionally substitute one manufacturer's generic for another, and those substitutions sometimes carry different cash-pay prices under discount card contracts.
In Texas, the shortage has been particularly acute in rural areas. A 2023 ASHP survey found that 85% of hospital and health-system pharmacists reported difficulty sourcing amphetamine products. [25] Retail pharmacy shortages translate directly to patient harm: patients who cannot fill their prescription on time face symptom rebound, lost workdays, and sometimes unsafe off-label substitution with non-stimulant agents that have slower onset.
Calling ahead to confirm stock before submitting a prescription is a practical step, especially in smaller Texas cities and towns. HEB Pharmacy, the largest Texas-based grocery pharmacy chain, has historically maintained better stimulant inventory than national chains during shortage periods due to regional purchasing relationships, though this is not guaranteed.
[26]
Pediatric Versus Adult Dosing and Cost Implications
FDA labeling for Adderall XR approves the drug for ADHD in patients ages 6 and older. [1] Children typically start at 5 to 10 mg once daily, while adults typically start at 20 mg once daily. Lower doses cost less in absolute terms per capsule but not always per milligram. The 5 mg capsule at many Texas pharmacies costs nearly as much per fill as the 10 mg or 15 mg capsule because of fixed dispensing fees.
The National Institute of Mental Health funded the Multimodal Treatment Study of Children with ADHD (MTA, N=579), which demonstrated that carefully titrated stimulant medication produced statistically superior outcomes on teacher and parent ADHD rating scales compared to community care (effect size 0.8) at 14 months. [2] That evidence base supports long-term prescribing in children, which means families must plan for monthly prescription costs over years, not weeks.
Texas CHIP covers stimulants for pediatric ADHD when prior authorization criteria are met. [5] Families with household incomes up to 201% of the federal poverty level may qualify for CHIP, reducing or eliminating out-of-pocket stimulant costs for children. The application is processed through Texas Health and Human Services. [27]
[28]
Monitoring Requirements That Affect Total Annual Cost
Adderall XR prescribing in Texas is not a one-time cost. DEA Schedule II rules prohibit refills; each month requires a new prescription, which in most clinical settings requires a follow-up appointment. Texas law does not require monthly in-person visits for established controlled substance patients, but most prescribers schedule quarterly check-ins at minimum.
The American Heart Association recommends baseline and periodic cardiovascular monitoring for patients on stimulants, including blood pressure and heart rate assessment. [29] A 2008 AHA scientific statement specifically addressed stimulant use in children with heart conditions, recommending an ECG before initiating therapy in children with cardiac risk factors. That monitoring adds laboratory and office visit costs to the total annual burden.
Texas also requires prescribers to check the PMP AWARxE database before issuing Schedule II prescriptions for new patients. [30] The PMP check itself is free for prescribers, but the workflow adds time to visits, which can affect appointment availability and cost.
The FDA's 2023 update to Adderall labeling reinforced warnings about cardiovascular risks, psychiatric adverse effects, and growth effects in pediatric patients, all of which require monitoring that generates healthcare costs beyond the drug itself. [1]
[31]
Practical Checklist Before Your First Texas Adderall XR Fill
Patients and caregivers navigating the Texas stimulant market for the first time face a compressed set of decisions at the pharmacy counter. Running through these steps before leaving the prescriber's office reduces the chance of a costly or delayed first fill.
First, confirm the pharmacy has the prescribed strength in stock. Pharmacies are required to fill a Schedule II prescription within a defined window, but shortages mean stock may be unavailable. Second, ask the prescriber to specify a generic in addition to brand on the prescription; Texas allows "dispense as written" or "substitution permitted," and the latter opens the door to generic pricing. Third, compare prices across at least two pharmacies using GoodRx or RxSaver before dropping off the paper prescription. Schedule II prescriptions in Texas may be electronic (e-prescribing for controlled substances, EPCS), and most pharmacies now accept them, but a paper copy remains a backup option under Texas law.
Fourth, if the patient holds commercial insurance, call the plan's pharmacy benefit line to confirm the tier and whether prior authorization is required before submitting. A prior authorization denial at the pharmacy counter delays treatment and wastes a prescription blank. Fifth, document the visit thoroughly; a well-documented diagnosis, prior treatment history, and functional impairment assessment strengthens any prior authorization appeal and may be needed if the patient ever switches insurers.
[32]
Frequently asked questions
›How much does Adderall XR cost in Texas in 2026?
›Does Texas Medicaid cover Adderall XR?
›Is compounded mixed amphetamine salts legal in Texas?
›Can I get Adderall XR via telehealth in Texas?
›Which insurance plans cover Adderall XR in Texas?
›What's the cheapest way to get Adderall XR in Texas?
›Are there Texas Adderall XR discount programs?
›How does the Teva generic savings card work in Texas?
References
- U.S. Food and Drug Administration. Adderall XR (mixed amphetamine salts extended-release) prescribing information. AccessData FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021303s026lbl.pdf
- MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1073-1086. https://pubmed.ncbi.nlm.nih.gov/10591282/
- National Institute of Mental Health. Attention-deficit/hyperactivity disorder. NIH. https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd
- Texas Health and Human Services. Texas Vendor Drug Program formulary. https://www.hhs.texas.gov/providers/pharmacy-providers/vendor-drug-program
- Texas Health and Human Services. CHIP benefits and covered services. https://www.hhs.texas.gov/services/health/childrens-health-insurance-program-chip
- Wolraich ML, Chan E, Froehlich T, et al. ADHD Diagnosis and Treatment Guidelines: A Historical Perspective. Pediatrics. 2019;144(4):e20191682. https://pubmed.ncbi.nlm.nih.gov/31570648/
- Centers for Medicare and Medicaid Services. Medicaid covered outpatient prescription drugs. CMS.gov. https://www.medicaid.gov/medicaid/prescription-drugs/covered-outpatient-drugs/index.html
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and answers. FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- U.S. Drug Enforcement Administration. Practitioner's manual: Schedules of controlled substances. DEA.gov. https://www.dea.gov/practitioners-manual
- U.S. Food and Drug Administration. Pharmacy compounding: 503A. FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-pharmacies
- U.S. Drug Enforcement Administration. Electronic prescriptions for controlled substances (EPCS). DEA.gov. https://www.deadiversion.usdoj.gov/ecomm/e_rx/
- National Institute on Drug Abuse. Prescription stimulants: Drug facts. NIH/NIDA. https://www.drugabuse.gov/publications/drugfacts/prescription-stimulants
- U.S. Drug Enforcement Administration. Telemedicine regulations for prescription of controlled substances. DEA.gov. https://www.dea.gov/telemedicine
- Drug Enforcement Administration. Telemedicine prescribing of controlled substances when patient has not had prior in-person evaluation. Federal Register. 2023;88(65):12875. https://www.federalregister.gov/documents/2023/03/01/2023-04248/telemedicine-prescribing-of-controlled-substances-when-patient-has-not-had-prior-in-person
- Texas Medical Board. Rule 174.12: Telemedicine medical services. Texas Administrative Code. https://www.tmb.state.tx.us/page/telemedicine
- Centers for Disease Control and Prevention. Mental health treatment among adults: United States, 2019. CDC NCHS Data Brief. https://www.cdc.gov/nchs/data/databriefs/db380-H.pdf
- Blue Cross Blue Shield of Texas. Prescription drug formulary information. BCBSTX.com. https://www.bcbstx.com/member/prescription-drug-coverage
- Centers for Medicare and Medicaid Services. Mental health parity and addiction equity. CMS.gov. https://www.cms.gov/marketplace/technical-assistance-resources/mental-health-parity
- U.S. Department of Labor. ERISA and employee benefit plans. DOL.gov. https://www.dol.gov/agencies/ebsa/about-ebsa/our-activities/resource-center/faqs/health-plans-and-benefits
- American Academy of Family Physicians. Using prescription discount cards: What patients need to know. AAFP.org. https://www.aafp.org/news/health-of-the-public/20191015prescriptiondiscountcards.html
- U.S. Food and Drug Administration. Drug pricing transparency resources. FDA.gov. https://www.fda.gov/patients/drug-development-process/drug-pricing-and-competition
- National Institutes of Health. Patient assistance programs for prescription drugs. NIH MedlinePlus. https://medlineplus.gov/ency/patientinstructions/000618.htm
- Centers for Medicare and Medicaid Services. Medicaid drug rebate program. CMS.gov. https://www.medicaid.gov/medicaid/prescription-drugs/medicaid-drug-rebate-program/index.html
- U.S. Food and Drug Administration. FDA drug shortages database. FDA.gov. https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine+Mixed+Salts+%28Adderall%29+Tablet&st=c
- American Society of Health-System Pharmacists. Drug shortage statistics. ASHP.org. https://www.ashp.org/drug-shortages/shortage-resources/drug-shortage-statistics
- National Institutes of Health. ADHD medications: What you need to know. NIH MedlinePlus. https://medlineplus.gov/adhd.html
- Texas Health and Human Services. Apply for CHIP or Medicaid. HHS.Texas.gov. https://www.hhs.texas.gov/services/financial/medicaid-chip/apply-benefits
- Faraone SV, Biederman J, Morley CP, Spencer TJ. Effect of stimulants on height and weight: A review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(9):994-1009. https://pubmed.ncbi.nlm.nih.gov/18664994/
- Vetter VL, Elia J, Erickson C, et al. Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs. Circulation. 2008;117(18):2407-2423. https://pubmed.ncbi.nlm.nih.gov/18427125/
- Texas State Board of Pharmacy. PMP AWARxE program for prescribers. TSBP.texas.gov. https://www.pharmacy.texas.gov/pmp/
- U.S. Food and Drug Administration. Adderall XR (amphetamine) risk management. FDA.gov. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/adderall-amphetamine
- Pliszka S; AAC